REG - iFOREX Financial - Admission to trading on the London Stock Exchange

Midland HoldingsAnnouncement

25/02/2026 08:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260225:nRSY2443Ua&default-theme=true

RNS Number : 2443U  iFOREX Financial Trading Hldngs Ltd  25 February 2026

THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR
PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, CANADA,
AUSTRALIA, SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION WHERE SUCH
DISTRIBUTION WOULD BE UNLAWFUL.

Neither this announcement, nor anything contained herein, shall form the basis
of, or be relied upon in connection with, any offer or commitment whatsoever
in any jurisdiction. Investors should not purchase any shares referred to in
this announcement except solely on the basis of the information in the
prospectus (the "Prospectus"), including the risk factors set out therein,
published by iFOREX Financial Trading Holdings Ltd. (the "Company" and,
together with its subsidiaries, the "Group") and approved by the FCA on 19
February 2026 in relation to the offer (the "Offer") of ordinary shares in the
Company (the "Ordinary Shares") and the admission of such Ordinary Shares to
the equity shares (commercial companies) segment of the Official List of the
FCA and to trading on the Main Market for listed securities of London Stock
Exchange plc (the "London Stock Exchange") (together, "Admission").

 

 

25 February 2026

iFOREX Financial Trading Holdings Ltd.

(trading as "iFOREX")

("iFOREX", the "Company" or the "Group")

 

Admission to trading on the London Stock Exchange

 

Further to the announcement on 19 February 2026 in connection with its initial
public offering, iFOREX announces that its entire issued ordinary share
capital, consisting of 22,186,679 Ordinary Shares, has today been admitted to
the equity shares (commercial companies) category of the Official List of the
Financial Conduct Authority (the "FCA") and to trading on London Stock
Exchange plc's main market for listed securities under the ticker "IFRX".

Following Admission, the share capital of the Company will consist of
22,186,679 Ordinary Shares, each with one vote per share. The Company does not
hold any Ordinary Shares in treasury. Therefore, the total voting rights
figure of 22,186,679 may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under the FCA's
Disclosure Guidance and Transparency Rules.

Itai Sadeh, CEO of iFOREX, commented:

"Admission onto the Main Market of the London Stock Exchange marks a proud
moment for iFOREX as we accelerate our vision to become a global fintech
market leader. I would like to extend my sincere thanks to our new investors
for their support in our vision, and to our employees whose dedication and
talent have brought us to this point. The strong interest in our initial
public offering reflects the solid foundation and growth potential we have
built together. With a clear strategy, proprietary technology, and a robust
platform focused on international expansion, we are well placed to embrace the
opportunities ahead and deliver long-term sustainable value for our clients
and shareholders."

 

Enquiries:

 Public Relations Adviser to iFOREX

 Camarco

 Marc                                                                                                                                                                                            020 3757 4980
 Cohen

                                                                                                                                                                                               iForex@camarco.co.uk
 Phoebe Pugh

 Sponsor and Sole Bookrunner

 Shore Capital

 Simon Fine, Patrick Castle, Tom Knibbs, George Payne                                                                                                                                            020 7408 4090

 

IMPORTANT LEGAL INFORMATION

The information contained in this announcement is for background purposes only
and does not purport to be full or complete. No reliance may be placed by any
person for any purpose on the information contained in this announcement or on
its accuracy, fairness or completeness.

This announcement is not for publication, distribution or release, in whole or
in part, directly or indirectly, in or into the United States of America. This
announcement is not an offer of securities for sale into the United States.
The securities referred to herein have not been and will not be registered
under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or
with any securities regulatory authority of any state or other jurisdiction of
the United States, and may not be offered, sold, resold, renounced,
transferred, delivered or distributed, directly or indirectly, in any form, in
or into, the United States, except pursuant to an applicable exemption from,
or in a transaction not subject to, the registration requirements under the
Securities Act. No public offering or sale of securities in the United States
will be made.

This announcement is not for publication, distribution or release, in whole or
in part, directly or indirectly, in or into Australia, the Republic of South
Africa, Japan, Canada or any other jurisdiction where such distribution may
lead to a breach of any legal or regulatory requirement (each a "Restricted
Jurisdiction"). The Ordinary Shares have not been, and will not be, registered
under the applicable securities laws of (and clearances have not been, and
will not be, obtained from the relevant securities authorities or commissions
of) any Restricted Jurisdiction. The distribution of this announcement in or
into (or to persons or residents in, or citizens of) jurisdictions outside of
the United Kingdom may be restricted by law and persons into whose possession
this announcement comes should inform themselves about, and observe, any such
restrictions. Any failure to comply with these restrictions may constitute a
violation of the laws of the relevant jurisdiction.

This announcement is only addressed to and directed at specific addressees
who: (A) if in a member state of the European Economic Area (the "EEA"), are
persons who are "qualified investors" within the meaning of Article 2(e) of
Regulation (EU) 2017/1129 (as amended) (the "Prospectus Regulation")
("Qualified Investors"); (B) if in the United Kingdom, are "qualified
investors" within the meaning of paragraph 15 of Schedule 1 of the Public
Offers and Admissions to Trading Regulations 2024 ("POATR"),  who are: (i)
persons having professional experience in matters relating to investments who
fall within the definition of "investment professionals" in Article 19(5) of
the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005,
as amended (the "Order"); or (ii) high net worth entities falling within
Article 49(2)(a) to (d) of the Order; or (iii) other persons to whom an
invitation or inducement to engage in investment activity (within the meaning
of section 21 of FSMA) in connection with the sale of any securities of the
Company or any member of its group may otherwise lawfully be communicated or
caused to be communicated (all such persons referred to in (i), (ii) and (iii)
together being "Relevant Persons"), and (C) if in Israel, persons who are
investors listed in the first addendum (the "Addendum") to the Israeli
Securities Law, 5728-1968, consisting primarily of joint investment in trust
funds; provident funds; insurance companies; banks; portfolio managers,
investment advisers, members of the Tel Aviv Stock Exchange Ltd.,
underwriters, each purchasing for their own account; venture capital funds;
entities with equity in excess of NIS 50 million and "qualified individuals,"
each as defined in the Addendum (as it may be amended from time to time),
collectively referred to as "Qualified Israeli Investors". This announcement
must not be acted on or relied on (i) in the United Kingdom, by persons who
are not Relevant Persons, (ii) in any member state of the EEA by persons who
are not Qualified Investors, and in (iii) in Israel by persons who are not
Qualified Israeli Investors. Any investment activity to which this
announcement relates (i) in the United Kingdom is available only to, and may
be engaged in only with, Relevant Persons, (ii) in any member state of the EEA
is available only to, and may be engaged only with, Qualified Investors, and
(iii) in Israel is available only to, and may be engaged only with, Qualified
Israeli Investors.

Any subscription or purchase of Ordinary Shares should be made solely on the
basis of information contained in the Prospectus published by the Company on
19 February 2026 in connection with the Offer. The information in this
announcement is subject to change. Before subscribing for or purchasing any
Ordinary Shares, persons viewing this announcement should ensure that they
fully understand and accept the risks which will be set out in the Prospectus.
No reliance may be placed for any purpose on the information contained in this
announcement or its accuracy, fairness or completeness. Neither this
announcement, nor anything contained in the Prospectus, shall constitute, or
form part of, any offer or invitation to sell or issue, or any solicitation of
any offer to acquire, whether by subscription or purchase, any Ordinary Shares
or any other securities, nor shall it (or any part of it), or the fact of its
distribution, form the basis of, or be relied on in connection with, or act as
any inducement to enter into, any contract or commitment whatsoever.

Potential investors should not base their financial decision on this
announcement. Acquiring investments to which this announcement relates may
expose an investor to a significant risk of losing all of the amount invested.
Persons considering making investments should consult an authorised person
specialising in advising on such investments. Neither this announcement, nor
the Prospectus, constitutes a recommendation concerning an offer. The value of
shares can decrease as well as increase. Potential investors should consult a
professional adviser as to the suitability of the Offer for the person
concerned.

Nothing contained herein constitutes or should be construed as (i) investment,
tax, financial, accounting or legal advice, (ii) a representation that any
investment or strategy is suitable or appropriate to your individual
circumstances or (iii) a personal recommendation to you.

Apart from the responsibilities and liabilities, if any, which may be imposed
on Shore Capital or Shore Capital Stockbrokers Limited by FSMA or the
regulatory regime established thereunder, or under the regulatory regime of
any jurisdiction where the exclusion of liability under the relevant
regulatory regime would be illegal, void or unenforceable, none of Shore
Capital nor Shore Capital Stockbrokers Limited nor any of their respective
affiliates and/or any of their or their affiliates' directors, officers,
employees, advisers and/or agents accepts any responsibility or liability
whatsoever for, or makes any representation or warranty, express or implied,
as to, the truth, accuracy or completeness of the information in this
announcement (or whether any information has been omitted from the
announcement) and/or any other information relating to the Company, the Group
or its associated companies, whether written, oral or in a visual or
electronic form, and howsoever transmitted or made available, or for any loss
howsoever arising from any use of this announcement or its contents or
otherwise arising in connection therewith.

Shore Capital and Shore Capital Stockbrokers Limited are authorised and
regulated by the FCA in the United Kingdom and are acting exclusively for the
Company and no one else in connection with the Offer. Shore Capital and Shore
Capital Stockbrokers Limited will not regard any other person (whether or not
a recipient of this announcement) as their client in relation to the Offer and
will not be responsible to anyone other than the Company for providing the
protections afforded to their respective clients nor for giving advice in
relation to the Offer, the contents of this announcement or any transaction,
arrangement or other matter referred to herein.

For the avoidance of doubt, the contents of the Group's website, or any
website directly or indirectly linked to the Group's website, are not
incorporated by reference into, and do not form part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  LISVZLFLQLLXBBX



            Copyright 2019 Regulatory News Service, all rights reserved